The plant molecular farming market is revolutionizing biopharmaceutical production by using plants to manufacture vaccines, antibodies, and enzymes. It offers cost savings, scalability, and sustainability. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Plant Molecular Farming Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Plant Molecular Farming Market, by Product Type
8.1.1. Therapeutic Proteins
8.1.1.1. Market Revenue and Forecast
8.1.2. Vaccines
8.1.2.1. Market Revenue and Forecast
8.1.3. Industrial Enzymes
8.1.3.1. Market Revenue and Forecast
8.1.4. Nutraceuticals and Functional Foods
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast
9.1. Plant Molecular Farming Market, by Plant Type/Expression System
9.1.1. Tobacco-based Systems
9.1.1.1. Market Revenue and Forecast
9.1.2. Cereals (Rice, Maize, Barley)
9.1.2.1. Market Revenue and Forecast
9.1.3. Legumes (Soybean, Pea)
9.1.3.1. Market Revenue and Forecast
9.1.4. Leafy Crops (Spinach, Lettuce)
9.1.4.1. Market Revenue and Forecast
9.1.5. Other Plant Systems
9.1.5.1. Market Revenue and Forecast
10.1. Plant Molecular Farming Market, by Production Method
10.1.1. Transient Expression
10.1.1.1. Market Revenue and Forecast
10.1.2. Stable Expression
10.1.2.1. Market Revenue and Forecast
10.1.3. Hairy Root Cultures
10.1.3.1. Market Revenue and Forecast
10.1.4. Plant Cell Suspension Cultures
10.1.4.1. Market Revenue and Forecast
11.1. Plant Molecular Farming Market, by End User
11.1.1. Pharmaceutical and Biotechnology Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Contract Development and Manufacturing Organizations (CDMOs)
11.1.2.1. Market Revenue and Forecast
11.1.3. Research Institutes and Academic Centers
11.1.3.1. Market Revenue and Forecast
11.1.4. Nutraceutical and Food Companies
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product Type
12.1.2. Market Revenue and Forecast, by Plant Type/Expression System
12.1.3. Market Revenue and Forecast, by Production Method
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product Type
12.1.5.2. Market Revenue and Forecast, by Plant Type/Expression System
12.1.5.3. Market Revenue and Forecast, by Production Method
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product Type
12.1.6.2. Market Revenue and Forecast, by Plant Type/Expression System
12.1.6.3. Market Revenue and Forecast, by Production Method
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product Type
12.2.2. Market Revenue and Forecast, by Plant Type/Expression System
12.2.3. Market Revenue and Forecast, by Production Method
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product Type
12.2.5.2. Market Revenue and Forecast, by Plant Type/Expression System
12.2.5.3. Market Revenue and Forecast, by Production Method
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product Type
12.2.6.2. Market Revenue and Forecast, by Plant Type/Expression System
12.2.6.3. Market Revenue and Forecast, by Production Method
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product Type
12.2.7.2. Market Revenue and Forecast, by Plant Type/Expression System
12.2.7.3. Market Revenue and Forecast, by Production Method
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product Type
12.2.8.2. Market Revenue and Forecast, by Plant Type/Expression System
12.2.8.3. Market Revenue and Forecast, by Production Method
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product Type
12.3.2. Market Revenue and Forecast, by Plant Type/Expression System
12.3.3. Market Revenue and Forecast, by Production Method
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product Type
12.3.5.2. Market Revenue and Forecast, by Plant Type/Expression System
12.3.5.3. Market Revenue and Forecast, by Production Method
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product Type
12.3.6.2. Market Revenue and Forecast, by Plant Type/Expression System
12.3.6.3. Market Revenue and Forecast, by Production Method
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product Type
12.3.7.2. Market Revenue and Forecast, by Plant Type/Expression System
12.3.7.3. Market Revenue and Forecast, by Production Method
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product Type
12.3.8.2. Market Revenue and Forecast, by Plant Type/Expression System
12.3.8.3. Market Revenue and Forecast, by Production Method
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product Type
12.4.2. Market Revenue and Forecast, by Plant Type/Expression System
12.4.3. Market Revenue and Forecast, by Production Method
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product Type
12.4.5.2. Market Revenue and Forecast, by Plant Type/Expression System
12.4.5.3. Market Revenue and Forecast, by Production Method
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product Type
12.4.6.2. Market Revenue and Forecast, by Plant Type/Expression System
12.4.6.3. Market Revenue and Forecast, by Production Method
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product Type
12.4.7.2. Market Revenue and Forecast, by Plant Type/Expression System
12.4.7.3. Market Revenue and Forecast, by Production Method
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product Type
12.4.8.2. Market Revenue and Forecast, by Plant Type/Expression System
12.4.8.3. Market Revenue and Forecast, by Production Method
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product Type
12.5.2. Market Revenue and Forecast, by Plant Type/Expression System
12.5.3. Market Revenue and Forecast, by Production Method
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product Type
12.5.5.2. Market Revenue and Forecast, by Plant Type/Expression System
12.5.5.3. Market Revenue and Forecast, by Production Method
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product Type
12.5.6.2. Market Revenue and Forecast, by Plant Type/Expression System
12.5.6.3. Market Revenue and Forecast, by Production Method
12.5.6.4. Market Revenue and Forecast, by End User
13.1. Medicago Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Kentucky BioProcessing (KBP)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Protalix Biotherapeutics
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Icon Genetics GmbH
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. PlantForm Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. iBio Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Ventria Bioscience
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Synthon Biopharmaceuticals
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Fraunhofer IME
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. ORF Genetics
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description